Share Facebook Twitter LinkedIn Pinterest Email ESSA Pharma director Franklin Berger buys common shares worth ~$133.3K
Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix (NASDAQ:FLGT)February 27, 2026